Physician profile
Jeff P Steinhoff
NPI 1811959869
$39,634.31
in general payments reported to CMS, 2019-2025
54 companies · $2,952 in 2025
The $2,952 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $1,978 · 2021: $2,620 · 2022: $2,715 · 2023: $2,383 · 2024: $4,779 · 2025: $2,952.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,004 · Travel and Lodging: $1,092 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,004.26 |
| Travel and Lodging | $1,092.32 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $10,627.29 | 2019-2023 | |
| Amgen INC. | $6,648.77 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $4,050.15 | 2019-2025 | Triclip, Navitor, Cardiomems |
| Regeneron Healthcare Solutions, INC. | $3,996.74 | 2019-2025 | Evkeeza |
| Boston Scientific Corporation | $2,380.85 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, General - Therapies, Opticross |
| Janssen Pharmaceuticals, INC | $1,310.59 | 2019-2024 | Xarelto |
| Medtronic, INC. | $1,076.58 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Micra |
| Novartis Pharmaceuticals Corporation | $984.58 | 2019-2025 | |
| Shockwave Medical, INC | $804.48 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $720.99 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $707.01 | 2019-2025 | Farxiga, Andexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $507.04 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $461.77 | 2019-2022 | |
| Novo Nordisk INC | $427.85 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Medtronic Vascular, INC. | $412.22 | 2019-2020 |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $378.13 | 2022-2025 | Impella |
| Edwards Lifesciences Corporation | $341.26 | 2020-2024 | |
| Ancora Heart, INC. | $315.76 | 2023-2024 | Accucinch |
| Angiodynamics, INC. | $295.68 | 2024 | Auryon Laser System 100-120 Vac |
| Merck Sharp & Dohme LLC | $248.69 | 2021-2024 | Verquvo |
| Cardiovascular Systems INC. | $196.43 | 2022-2023 | Diamondback Coronary |
| Bard Peripheral Vascular, INC. | $193.88 | 2023-2024 | Rotarexs 6 F X 135 Cm, Crosser Iq |
| E.R. Squibb & Sons, L.L.C. | $173.30 | 2021-2024 | Camzyos, Eliquis |
| Esperion Therapeutics, INC. | $166.53 | 2020-2025 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $162.62 | 2021-2025 | |
| Endologix LLC | $143.74 | 2019 | |
| Scpharmaceuticals INC. | $143.53 | 2024-2025 | |
| W. L. Gore & Associates, INC. | $130.01 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Alnylam Pharmaceuticals INC. | $129.32 | 2024-2025 | Onpattro |
| Terumo Medical Corporation | $123.93 | 2022 | |
| Philips North America LLC | $121.34 | 2025 | Labosys, Igt Devices Undivided |
| Kowa Pharmaceuticals America, INC. | $116.39 | 2019-2021 | |
| Inari Medical, INC. | $111.94 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Actelion Pharmaceuticals US, INC. | $109.05 | 2022-2025 | Opsumit |
| Kestra Medical Technology Services, INC. | $101.29 | 2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $96.84 | 2019-2025 | Lifevest |
| Lexicon Pharmaceuticals, INC. | $82.15 | 2023-2024 | Inpefa |
| Atricure, INC. | $79.00 | 2021-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Kiniksa Pharmaceuticals International, Plc | $57.34 | 2024 | Arcalyst |
| Cardiva Medical, INC. | $51.39 | 2025 | Savvywire, Optowire |
| Chiesi USA, INC. | $50.18 | 2019 | |
| Corcept Therapeutics | $46.09 | 2025 | Korlym |
| Biosense Webster, INC. | $46.09 | 2022 | |
| United Therapeutics Corporation | $45.14 | 2023-2025 | Tyvaso, Orenitram |
| Siemens Medical Solutions USA, INC. | $43.84 | 2022 | |
| Kiniksa Pharmaceuticals, Ltd. | $33.62 | 2021-2022 | |
| Vital Connect, INC | $31.06 | 2023-2025 | Vitalpatch Rtm |
| Lantheus Medical Imaging, INC. | $29.85 | 2021 | |
| Alexion Pharmaceuticals, INC. | $25.78 | 2021 | |
| Arbor Pharmaceuticals, INC. | $25.60 | 2019 | |
| Recor Medical INC | $25.26 | 2024 | Paradise Renal Denervation System |
| Lundbeck LLC | $19.48 | 2019 | |
| Portola Pharmaceuticals, LLC | $14.52 | 2019 | |
| Smith+Nephew, INC. | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeff Steinhoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.